US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

Edex

Reason Lack of Assurance of Sterility: Defective container resulting in the lack of sterility assurance. ok thanks

Endo Pharmaceuticals, Inc. NDC 52244-010-02 D-0512-2017
Class II · Moderate risk Terminated

Potassium PHOSphate in 0.5% Dextrose

Reason Labeling: Not Elsewhere Classified: Incorrect volume printed on the product label.

Pharmedium Services, LLC NDC 61553-0299-48 D-0908-2017
Class III · Low risk Terminated

Potassium CHLORide added to 0.9% Sodium Chloride

Reason Labeling: Not Elsewhere Classified: Incorrect volume printed on the product label.

Pharmedium Services, LLC NDC 61553-0856-48 D-0907-2017
Class III · Low risk Terminated

Potassium CHLORide added to 0.9% Sodium Chloride

Reason Labeling: Not Elsewhere Classified: Incorrect volume printed on the product label.

Pharmedium Services, LLC NDC 61553-0824-48 D-0906-2017
Class III · Low risk Terminated

Risedronate Sodium Delayed-release Tablets

Reason Failed Dissolution Specifications: low out of specification dissolution results found during stability testing.

Teva Pharmaceuticals USA NDC 0093-5509-19 D-0511-2017
Class II · Moderate risk Terminated

Dorama-Neo

Reason Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.

Sato Pharmaceutical Inc. NDC 49873-020-01 D-0856-2017
Class II · Moderate risk Terminated

Sato Clear

Reason Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.

Sato Pharmaceutical Inc. NDC 49873-044-01 D-0855-2017
Class II · Moderate risk Terminated

Optic Splash

Reason Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.

Sato Pharmaceutical Inc. NDC 49873-501-01 D-0854-2017
Class I · High risk Terminated

XtraHRD Natural Male Enhancement Capsules

Reason Marketed without an Approved NDA/ANDA: Product contains N-desmethyl tadalafil an analogue to tadalafil which is an active pharmaceutical ingredient in a FDA approved drug used to treat erectile dysfunction (ED).

Organic Herbal Supply D-0646-2017
Class II · Moderate risk Terminated

HealthA2Z CHEWABLE Aspirin

Reason cGMP deviations - presence of rubber particles found loose in the bulk product.

Allegiant Health D-0500-2017